Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...